Market closedNon-fractional
Pacira BioSciences/PCRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Pacira BioSciences
Ticker
PCRX
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Tampa, United States
Employees
712
Website
www.pacira.com
PCRX Metrics
BasicAdvanced
$930M
Market cap
14.11
P/E ratio
$1.42
EPS
0.87
Beta
-
Dividend rate
Price and volume
Market cap
$930M
Beta
0.87
Financial strength
Current ratio
5.812
Quick ratio
4.576
Long term debt to equity
63.232
Total debt to equity
65.21
Interest coverage (TTM)
6.66%
Management effectiveness
Return on assets (TTM)
3.67%
Return on equity (TTM)
8.49%
Valuation
Price to earnings (TTM)
14.106
Price to revenue (TTM)
1.359
Price to book
1.03
Price to tangible book (TTM)
3.54
Price to free cash flow (TTM)
5.348
Growth
Revenue change (TTM)
1.88%
Earnings per share change (TTM)
-694.99%
3-year revenue growth (CAGR)
15.45%
3-year earnings per share growth (CAGR)
-24.76%
What the Analysts think about PCRX
Analyst Ratings
Majority rating from 11 analysts.
PCRX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$167M
-7.78%
Net income
$8.9M
-64.11%
Profit margin
5.32%
-61.11%
PCRX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.78
$0.72
$0.89
$0.62
-
Expected
$0.76
$0.78
$0.88
$0.62
$0.68
Surprise
2.90%
-8.16%
0.75%
-0.64%
-
PCRX News
AllArticlesVideos
Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025
GlobeNewsWire·2 weeks ago
Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
GlobeNewsWire·2 months ago
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Pacira BioSciences stock?
Pacira BioSciences (PCRX) has a market cap of $930M as of July 27, 2024.
What is the P/E ratio for Pacira BioSciences stock?
The price to earnings (P/E) ratio for Pacira BioSciences (PCRX) stock is 14.11 as of July 27, 2024.
Does Pacira BioSciences stock pay dividends?
No, Pacira BioSciences (PCRX) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Pacira BioSciences dividend payment date?
Pacira BioSciences (PCRX) stock does not pay dividends to its shareholders.
What is the beta indicator for Pacira BioSciences?
Pacira BioSciences (PCRX) has a beta rating of 0.87. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Pacira BioSciences stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.